Skip to content
The Nexus
BUSINESSJun 3 · 20:45 UTCSTAT NEWSBrittany Trang

STAT+: Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeutics

Alnylam partners with Inceptive Nucleics to develop AI foundation models for RNAi therapeutics. The three-year collaboration is worth up to $2 billion, with $30 million upfront in cash and equity. Jakob Uszkoreit, former Google researcher, co-founded Inceptive Nucleics after contributing to foundational AI research.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting